Download
s00262-020-02587-8.pdf 1,59MB
WeightNameValue
1000 Titel
  • Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature
1000 Autor/in
  1. Watanabe, Tsubasa |
  2. Firat, Elke |
  3. Scholber, Jutta |
  4. Gaedicke, Simone |
  5. Heinrich, Corinne |
  6. Luo, Ren |
  7. Ehrat, Nicolas |
  8. Multhoff, Gabriele |
  9. Schmitt-Graeff, Annette |
  10. Grosu, Anca-Ligia |
  11. Abdollahi, Amir |
  12. Hassel, Jessica C. |
  13. von Bubnoff, Dagmar |
  14. Meiss, Frank |
  15. Niedermann, Gabriele |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-04-29
1000 Erschienen in
1000 Quellenangabe
  • 69(9):1823-1832
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00262-020-02587-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413872/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Radiotherapy can elicit abscopal effects in non-irradiated metastases, particularly under immune checkpoint blockade (ICB). We report on two elderly patients with oligometastatic melanoma treated with anti-PD-1 and stereotactic body radiation therapy (SBRT). Before treatment, patient 1 showed strong tumor infiltration with exhausted CD8+ T cells and high expression of T cell-attracting chemokines. This patient rapidly mounted a complete response, now ongoing for more than 4.5 years. Patient 2 exhibited low CD8+ T cell infiltration and high expression of immunosuppressive arginase. After the first SBRT, his non-irradiated metastases did not regress and new metastases occurred although neoepitope-specific and differentiation antigen-specific CD8+ T cells were detected in the blood. A second SBRT after 10 months on anti-PD-1 induced a radiologic complete response correlating with an increase in activated PD-1-expressing CD8 T cells. Apart from a new lung lesion, which was also irradiated, this deep abscopal response lasted for more than 2.5 years. However, thereafter, his disease progressed and the activated PD-1-expressing CD8 T cells dropped. Our data suggest that oligometastatic patients, where a large proportion of the tumor mass can be irradiated, are good candidates to improve ICB responses by RT, even in the case of an unfavorable pretreatment immune signature, after progression on anti-PD-1, and despite advanced age. Besides repeated irradiation, T cell epitope-based immunotherapies (e.g., vaccination) may prolong antitumor responses even in patients with unfavorable pretreatment immune signature.
1000 Sacherschließung
lokal Melanoma/therapy [MeSH]
lokal Female [MeSH]
lokal Immune checkpoint blockade
lokal Aged [MeSH]
lokal Abscopal effects
lokal Humans [MeSH]
lokal Melanoma/radiotherapy [MeSH]
lokal Immune signatures
lokal Radiosurgery/methods [MeSH]
lokal Original Article
lokal Epitopes, T-Lymphocyte/immunology [MeSH]
lokal Immunotherapy/methods [MeSH]
lokal Male [MeSH]
lokal Melanoma/immunology [MeSH]
lokal Programmed Cell Death 1 Receptor/immunology [MeSH]
lokal Hypofractionated radiotherapy
lokal CD8-Positive T-Lymphocytes/immunology [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2F0YW5hYmUsIFRzdWJhc2E=|https://frl.publisso.de/adhoc/uri/RmlyYXQsIEVsa2U=|https://frl.publisso.de/adhoc/uri/U2Nob2xiZXIsIEp1dHRh|https://frl.publisso.de/adhoc/uri/R2FlZGlja2UsIFNpbW9uZQ==|https://frl.publisso.de/adhoc/uri/SGVpbnJpY2gsIENvcmlubmU=|https://frl.publisso.de/adhoc/uri/THVvLCBSZW4=|https://frl.publisso.de/adhoc/uri/RWhyYXQsIE5pY29sYXM=|https://frl.publisso.de/adhoc/uri/TXVsdGhvZmYsIEdhYnJpZWxl|https://frl.publisso.de/adhoc/uri/U2NobWl0dC1HcmFlZmYsIEFubmV0dGU=|https://frl.publisso.de/adhoc/uri/R3Jvc3UsIEFuY2EtTGlnaWE=|https://frl.publisso.de/adhoc/uri/QWJkb2xsYWhpLCBBbWly|https://frl.publisso.de/adhoc/uri/SGFzc2VsLCBKZXNzaWNhIEMu|https://frl.publisso.de/adhoc/uri/dm9uIEJ1Ym5vZmYsIERhZ21hcg==|https://frl.publisso.de/adhoc/uri/TWVpc3MsIEZyYW5r|https://frl.publisso.de/adhoc/uri/TmllZGVybWFubiwgR2FicmllbGU=
1000 Hinweis
  • DeepGreen-ID: f89d3e50d0d143c0bd5308399fbcb1de ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470060.rdf
1000 Erstellt am 2023-11-18T03:35:56.108+0100
1000 Erstellt von 322
1000 beschreibt frl:6470060
1000 Zuletzt bearbeitet 2023-12-01T11:04:45.176+0100
1000 Objekt bearb. Fri Dec 01 11:04:45 CET 2023
1000 Vgl. frl:6470060
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470060 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source